全文获取类型
收费全文 | 4512篇 |
免费 | 333篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 126篇 |
妇产科学 | 145篇 |
基础医学 | 451篇 |
口腔科学 | 90篇 |
临床医学 | 361篇 |
内科学 | 1272篇 |
皮肤病学 | 109篇 |
神经病学 | 250篇 |
特种医学 | 130篇 |
外科学 | 839篇 |
综合类 | 115篇 |
一般理论 | 2篇 |
预防医学 | 252篇 |
眼科学 | 77篇 |
药学 | 245篇 |
中国医学 | 28篇 |
肿瘤学 | 336篇 |
出版年
2023年 | 75篇 |
2022年 | 168篇 |
2021年 | 291篇 |
2020年 | 178篇 |
2019年 | 220篇 |
2018年 | 272篇 |
2017年 | 163篇 |
2016年 | 144篇 |
2015年 | 152篇 |
2014年 | 201篇 |
2013年 | 256篇 |
2012年 | 347篇 |
2011年 | 316篇 |
2010年 | 200篇 |
2009年 | 135篇 |
2008年 | 214篇 |
2007年 | 251篇 |
2006年 | 234篇 |
2005年 | 191篇 |
2004年 | 178篇 |
2003年 | 134篇 |
2002年 | 143篇 |
2001年 | 34篇 |
2000年 | 34篇 |
1999年 | 29篇 |
1998年 | 21篇 |
1997年 | 15篇 |
1996年 | 12篇 |
1995年 | 22篇 |
1994年 | 20篇 |
1993年 | 18篇 |
1992年 | 20篇 |
1991年 | 13篇 |
1990年 | 21篇 |
1989年 | 20篇 |
1988年 | 21篇 |
1987年 | 8篇 |
1986年 | 8篇 |
1985年 | 12篇 |
1984年 | 4篇 |
1983年 | 7篇 |
1982年 | 6篇 |
1981年 | 4篇 |
1980年 | 5篇 |
1979年 | 4篇 |
1974年 | 5篇 |
1971年 | 3篇 |
1969年 | 4篇 |
1967年 | 3篇 |
1966年 | 3篇 |
排序方式: 共有4866条查询结果,搜索用时 15 毫秒
41.
Richard E Link Mohamad E Allaf Roberto Pili Louis R Kavoussi 《Journal of clinical oncology》2005,23(24):5762-5773
PURPOSE: Patients with clinical stage I nonseminomatous germ cell tumors (NSGCTs) have been managed with surveillance, chemotherapy, or retroperitoneal lymphadenectomy (RPLND) with similar survival outcomes. Cost factors influencing the choice of therapy were evaluated using computer-based decision analysis. METHODS: A detailed model was developed that integrates projected costs for more than 60 possible treatment outcomes. It incorporates primary, adjuvant, and salvage chemotherapy, primary and post-chemotherapy RPLND, and both laparoscopic and open surgical approaches. Starting values and probabilities were derived from a comprehensive meta-analysis of the last 25 years of testes cancer literature. Hypothesis testing was performed using sensitivity analysis. RESULTS: The model predicts a cost premium for both primary chemotherapy (18.7%) and RPLND (51.7%) compared with surveillance. If laparoscopic RPLND was practiced, the cost premium for primary surgery (29.1%) approached that of chemotherapy (26.4%). Open RPLND was 1.25x as costly as laparoscopic RPLND, primarily because of longer hospitalization. The choice of open RPLND yielded a 6.9% cost premium for a surveillance program in this model. For such a program, primary chemotherapy became cost advantageous when the probability of recurrence during surveillance was more than 46%. CONCLUSION: This model allows a variety of treatment cost hypotheses to be tested. Primary RPLND is never cost advantageous over surveillance or primary chemotherapy. Surgical costs can significantly increase the overall cost of a surveillance program. In stage I patients with high-risk tumor characteristics, primary chemotherapy may have a cost advantage over surveillance. 相似文献
42.
43.
Nur Aziah Hanapi Ahmad Saifuddin Mohamad Arshad Jafri Malin Abdullah Tengku Sifzizul Tengku Muhammad Siti R. Yusof 《Journal of pharmaceutical sciences》2021,110(2):698-706
Neurotherapeutic potentials of Centella asiatica and its reputation to boost memory, prevent cognitive deficits and improve brain functions are widely acknowledged. The plant's bioactive compounds, i.e. asiaticoside, madecassoside and asiatic acid were reported to have central nervous system (CNS) actions, particularly in protecting the brain against neurodegenerative disorders. Hence, it is important for these compounds to cross the blood-brain barrier (BBB) to be clinically effective therapeutics. This study aimed to explore the capability of asiaticoside, madecassoside and asiatic acid to cross the BBB using in vitro BBB model from primary porcine brain endothelial cells (PBECs). Our findings showed that asiaticoside, madecassoside and asiatic acid are highly BBB permeable with apparent permeability (Papp) of 70.61 ± 6.60, 53.31 ± 12.55 and 50.94 ± 10.91 × 10?6 cm/s respectively. No evidence of cytotoxicity and tight junction disruption of the PBECs were observed in the presence of these compounds. Asiatic acid showed cytoprotective effect towards the PBECs against oxidative stress. This study reported for the first time that Centella asiatica compounds demonstrated high capability to cross the BBB, comparable to central nervous system drugs, and therefore warrant further development as therapeutics for the treatment of neurodegenerative diseases. 相似文献
44.
Sarumathi Gobinathan Siti Solehah Zainol Siti Fatmah Azizi Nabil Mohamad Iman Rajasegaran Muniandy Hanis Nazihah Hasmad 《Journal of biomaterials science. Polymer edition》2013,24(17):2051-2067
AbstractAmniotic membrane has the potential to be used as scaffold in various tissue engineering applications. However, increasing its biostability at the same time maintaining its biocompatibility is important to enhance its usage as a scaffold. This studied characteristics genipin-crosslinked amniotic membrane as a bioscaffold. Redundant human amniotic membranes (HAM) divided into native (nAM), decellularized (dAM) and genipin-crosslinked (clAM) groups. The dAM and clAM group were decellularized using thermolysin (TL) and sodium hydroxide (NaOH) solution. Next, clAM group was crosslinked with 0.5% and 1.0% (w/v) genipin. The HAM was then studied for in vitro degradation, percentage of swelling, optical clarity, ultrastructure and mechanical strength. Meanwhile, fibroblasts isolated from nasal turbinates were then seeded onto nAM, dAM and clAM for biocompatibility studies. clAM had the slowest degradation rate and were still morphologically intact after 30 days of incubation in 0.01% collagenase type 1 solution. The dAM had a significantly highest percentage of swelling than other groups (p?<?0.05). Besides, the dAM retained the collagen content at similar level of nAM. Although the dAM had highest mechanical strength compared to the rest of the groups, the differences were statistically insignificant. Cell attachment on dAM and 0.5% clAM was higher compared to that on nAM and 1.0% clAM. In conclusion, clAM have better biostability and biocompatibility compared to the nAM and dAM. Together with other suitable characteristics of the clAM such as percentage of swelling, structural integrity and ECM content, clAM is suitable as scaffold for various tissue engineering applications. 相似文献
45.
46.
47.
Bana Agha Nasser Abdu Rahman Mesned Tagelden Mohamad Mohamad S. Kabbani 《Journal of the Saudi Heart Association》2016,28(1):59-62
Late presenting complete heart block after pediatric cardiac surgery is a rare complication and its management is well defined once the initial diagnosis in made timely and appropriately. In this report we described a child who underwent atrioventricular septal defect repair with a normal sinus rhythm during the postoperative period, as well as during the first 2 years of follow up.She subsequently developed complete heart block with bradycardia that required insertion of a pacemaker. Here we discuss this unusual late-presenting complication, possible risk factors, and management. 相似文献
48.
49.
Thiotepa‐based versus total body irradiation‐based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
下载免费PDF全文
![点击此处可从《European journal of haematology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Sandra Eder Myriam Labopin William Arcese Reuven Or Ignazio Majolino Andrea Bacigalupo Gennaro de Rosa Liisa Volin Dietrich Beelen Hendrik Veelken Nicolaas P. M. Schaap Jurgen Kuball Jan Cornelissen Arnon Nagler Mohamad Mohty the Acute Leukemia Working Party 《European journal of haematology》2016,96(1):90-97
Thiotepa is an alkylating compound with an antineoplastic and myeloablative activity and can mimic the effect of radiation. However, it is unknown whether this new regimen could safely replace the long‐established ones. This retrospective matched‐pair analysis evaluated the outcome of adults with acute myeloid leukaemia in first complete remission who received myeloablative conditioning either with a thiotepa‐based (n = 121) or a cyclophosphamide/total body irradiation‐based (TBI; n = 358) regimen for allogeneic hematopoietic stem cell transplantation from an HLA‐matched sibling or an unrelated donor. With a median follow‐up of 44 months, the outcome was similar in both groups. Acute graft‐versus‐host disease grade II‐IV was observed in 25% after thiotepa‐containing regimen versus 35% after TBI (P = 0.06). The 2‐yr cumulative incidence of chronic graft‐versus‐host disease was 40.5% for thiotepa and 41% for TBI (P = 0.98). At 2 yrs, the cumulative incidences of non‐relapse mortality and relapse incidence were 23.9% (thiotepa) vs. 22.4% (TBI; P = 0.66) and 17.2% (thiotepa) vs. 23.3% (TBI; P = 0.77), respectively. The probabilities of leukaemia‐free and overall survival at 2 yrs were not significantly different between the thiotepa and TBI groups, at 58.9% vs. 54.2% (P = 0.95) and 61.4% vs. 58% (P = 0.72), respectively. Myeloablative regimens using combinations including thiotepa can provide satisfactory outcomes, but the optimal conditioning remains unclear for the individual patient in this setting. 相似文献
50.